What's breaking now, across thousands of outlets.
Germany's Boehringer Ingelheim is further planting its stake in China, teaming up with Sino Biopharmaceutical in a cancer drug development deal that could balloon past $7 billion. Boehringer is delivering $358 million ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Eating a diet rich in red, yellow and orange fruits and vegetables may help reduce inflammation and exacerbations associated with chronic obstructive pulmonary disease (COPD), according to a new study…
The model and Rhode founder has talked before about the difficulty of premenstrual dysphoric disorder, a more severe form of premenstrual syndrome.
The Democratic flip of the Senate is expected to put two Democrats who support Medicare for All in charge of key committees.
We look at some of the key biotech developments, companies, and clinical data to watch at AHA Scientific Sessions 2026. The post From gene editing to RNA therapies: The biotech trends to look out for…
A world-first national program has discovered more than a third of babies thought to have a peanut allergy could safely have the diagnosis removed.
While substantial progress has been made against neglected tropical diseases (NTD), these are “uneven and fragile”, and several diseases are off course to meet 2030 targets.
